`

Henlius

Biotechnology Research

Specialities :
Monoclonal antibodies (mabs)
Innovative antibodies
Biosimilar
Oncology
Immunology

+1

revenue-icon Revenue
501M - 1B
funding-icon Total Funding
$156.0M
size-icon Size
201 - 500

Frequently Asked Questions About Henlius

What does Henlius do?+

Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable, and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases, and ophthalmic diseases. Up to date, 6 products have been launched in China, 3 has been approved for marketing in overseas markets, 24 indications are approved worldwide, and 3 marketing applications have been accepted for review in China, the U.S. and EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing...

What are Henlius's specialties? +

Monoclonal antibodies (mabs),innovative antibodies,biosimilar,oncology,immunology,and autoimmune diseases

What is Henlius's industry? +

Henlius operates in the Biotechnology research industry.

What is Henlius's revenue? +

Henlius's revenue is 501m - 1b

What is Henlius's company size? +

Henlius has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.